| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8722742 | HPB | 2018 | 5 Pages |
Abstract
In an appropriately-powered, single-institution prospective study, pasireotide was not validated as a preventive measure for pancreatic fistula.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Irmina A. Elliott, Amanda M. Dann, Razmik Ghukasyan, Lauren Damato, Mark D. Girgis, Jonathan C. King, O.J. Hines, Howard A. Reber, Timothy R. Donahue,